Caspase prime-side active-site characterization with non-hydrolyzable peptides assists in the design of a caspase-7-selective irreversible probe.
A. Solania, J. H. Xu, D. W. Wolan
The paper designs and characterizes non-hydrolyzable peptidomimetic inhibitors to selectively probe caspase-7 over caspase-3 by exploiting differences in their prime-side active-site architecture.
bioRxiv · Jan 30, 2024 · PreprintBiophysics